Michael Rugaard Jensen
-
- Advanced Combustion Engine Technologies 4
- Molecular Biology top 5%
- Heat shock proteins research 19
- ATP Synthase and ATPases Research 8
- RNA modifications and cancer 4
- Oncology top 5%
- Cancer-related Molecular Pathways 16
- Cancer Research top 5%
- Hepatology top 5%
-
- Toxin Mechanisms and Immunotoxins 5
-
- Microtubule and mitosis dynamics 5
-
- Cancer Research and Treatments 5
- Co-authors
- Kristian HelinDiego PasiniAdrian P. BrackenEros Lazzerini DenchiValentina M. FactorSnorri S. ThorgeirssonEric Santoni‐RugiuS S Thorgeirsson
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nature Genetics (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- SwitzerlandUnited StatesDenmark
In The Last Decade
Michael Rugaard Jensen
53 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Fluid Flow and Transfer Processes 220
- Molecular Biology 2.4k
- Oncology 697
- Cancer Research 376
- Hepatology 188
Countries citing papers authored by Michael Rugaard Jensen
This map shows the geographic impact of Michael Rugaard Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Rugaard Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Rugaard Jensen more than expected).
Fields of papers citing papers by Michael Rugaard Jensen
This network shows the impact of papers produced by Michael Rugaard Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Rugaard Jensen. The network helps show where Michael Rugaard Jensen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Rugaard Jensen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2020 | 2 | |
| 3 | 2014 | 2 | |
| 4 | 2013 | 56 | |
| 5 | 2012 | 57 | |
| 6 | 2010 | 50 | |
| 7 | Toward the optimization of stent-based treatment for coronary artery disease. | 2010 | 3 |
| 8 | Abstract #5649: Pharmakokinetic/phamacodynamic relationship of the HSP90 inhibitor NVP-AUY922 in human xenografts and patients in a clinical Phase I trial | 2009 | 2 |
| 9 | 2009 | 36 | |
| 10 | 2009 | 14 | |
| 11 | 2004 | 42 | |
| 12 | Suz12 is essential for mouse development and for EZH2 histone methyltransferase activitybreakdown → | 2004 | 703 |
| 13 | 2003 | 54 | |
| 14 | 2002 | 169 | |
| 15 | 2002 | 62 | |
| 16 | 1999 | 13 | |
| 17 | 1998 | 1 | |
| 18 | 1997 | 33 | |
| 19 | 1997 | 10 | |
| 20 | 1989 | 38 |
About Michael Rugaard Jensen
Michael Rugaard Jensen is a scholar working on Oncology, Fluid Flow and Transfer Processes and Biotechnology, having authored 53 papers that have together received 3.3k indexed citations. Recurring topics across this work include Heat shock proteins research (19 papers), Cancer-related Molecular Pathways (16 papers), ATP Synthase and ATPases Research (8 papers), Toxin Mechanisms and Immunotoxins (5 papers), Microtubule and mitosis dynamics (5 papers), Cancer Research and Treatments (5 papers), Advanced Combustion Engine Technologies (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Fluid Flow and Transfer Processes (220 citations), Molecular Biology (2.4k citations) and Oncology (697 citations). Michael Rugaard Jensen has collaborated with scholars based in Switzerland, United States and Denmark. Frequent co-authors include Kristian Helin, Diego Pasini, Adrian P. Bracken, Eros Lazzerini Denchi, Valentina M. Factor, Snorri S. Thorgeirsson, Eric Santoni‐Rugiu, S S Thorgeirsson, Elbert Hendricks and Carlos Garcı́a-Echeverrı́a. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.